Neuberger Berman Group LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$627,477
-15.9%
10,675
-14.3%
0.00%0.0%
Q4 2023$745,736
+94.9%
12,458
+196.5%
0.00%
Q2 2023$382,711
-85.8%
4,201
-89.7%
0.00%
-100.0%
Q1 2023$2,687,738
-6.3%
40,748
-26.6%
0.00%
-33.3%
Q4 2022$2,869,802
-5.2%
55,498
+25.2%
0.00%0.0%
Q3 2022$3,028,000
+52.0%
44,334
+0.7%
0.00%
+50.0%
Q2 2022$1,992,000
-6.4%
44,044
+5.1%
0.00%0.0%
Q1 2022$2,129,000
-54.5%
41,906
-58.6%
0.00%
-50.0%
Q4 2021$4,680,000
+121.2%
101,123
+57.5%
0.00%
+100.0%
Q3 2021$2,116,00064,1960.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 624,962$20,599,00013.29%
Octagon Capital Advisors LP 1,595,911$52,601,00012.95%
Logos Global Management LP 1,450,000$47,792,0003.45%
Avoro Capital Advisors LLC 5,000,000$164,800,0002.59%
Ghost Tree Capital, LLC 200,000$6,592,0001.93%
Integral Health Asset Management, LLC 190,000$6,262,0001.80%
GREAT POINT PARTNERS LLC 200,000$6,592,0001.54%
Aufman Associates Inc 53,642$1,768,0001.45%
Ghost Tree Capital, LLC 150,000$4,944,0001.45%
Altium Capital Management LP 166,700$5,494,0001.44%
View complete list of APELLIS PHARMACEUTICALS INC shareholders